From Financialisation to Innovation in UK Big Pharma: Astrazeneca and Glaxosmithkline

ISBN-13: 9781009278164 / Angielski / MiÄ™kka / 2022 / 75 str.

William Lazonick

Opis

This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline.

Recenzje

'The authors give us an exciting, solidly based exploration of the shifting links between financialization and new drug development at two leading British pharmaceutical giants, AstraZeneca and GlaxoSmithKline. As Covid has made clear, we all have a stake in this history.' Louis Galambos, Research Professor, History, Johns Hopkins University

Spis treści

1. Introduction; 2. Innovation and Competition in the Global Pharmaceutical Industry; 3. The Innovation-Financialisation Tension in the Global Pharmaceutical Industry; 4. AstraZeneca; 5. GlaxoSmithKline; 6. Explaining the Financialisation-to-Innovation Transition at AstraZeneca and GlaxoSmithKline; Appendix; References.